<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">20383481</PMID>
      <DateCompleted>
        <Year>2010</Year>
        <Month>11</Month>
        <Day>22</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1432-1289</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>51</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2010</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Der Internist</Title>
          <ISOAbbreviation>Internist (Berl)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[Graves' ophthalmopathy].</ArticleTitle>
        <Pagination>
          <StartPage>584</StartPage>
          <MedlinePgn>584, 586-8, 590-2, passim</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00108-009-2497-5</ELocationID>
        <Abstract>
          <AbstractText>Graves' orbitopathy is part of an autoimmune systemic disease which compiles hyperthyroidism, orbitopathy, dermopathy and acropachy. Stimulating antibodies against the TSH receptor play the central pathogenetic role. Main symptoms of Graves' orbitopathy comprise soft tissue inflammation, proptosis impairment of ocular motility and lid retraction. Inflammatory reactions of orbital fibroblasts are responsible for the symptoms. To restrict damage anti-inflammatory therapy (mainly systemic steroids, orbital irradiation) is indicated in moderate to severe active disease stages, and surgical orbital decompression in sight threatening states. In mild cases expectant strategy and selenium administration is sufficient. In inactive disease stages surgery is performed to improve appearance and function. Restoring euthyroidism leads to improvement of Graves' orbitopathy in about 60% of the patients. Radioiodine therapy without glucocorticoids is associated with a small but significant risk (15%) of deterioration or relapse. Thyroidectomy is neutral in later stages but may improve Graves' orbitopathy in early active stages.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Eckstein</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Zentrum für Augenheilkunde, Universitätsklinikum, Hufelandstrasse 55 , 45122, Essen, Deutschland. anja.eckstein@uk-essen.de</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Esser</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
          </Author>
        </AuthorList>
        <Language>ger</Language>
        <PublicationTypeList>
          <PublicationType UI="D004740">English Abstract</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Endokrine Orbitopathie.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Internist (Berl)</MedlineTA>
        <NlmUniqueID>0264620</NlmUniqueID>
        <ISSNLinking>0020-9554</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007457">Iodine Radioisotopes</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D019275">Radiopharmaceuticals</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049970" MajorTopicYN="N">Graves Ophthalmopathy</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007457" MajorTopicYN="N">Iodine Radioisotopes</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019275" MajorTopicYN="N">Radiopharmaceuticals</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013965" MajorTopicYN="Y">Thyroidectomy</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2010</Year>
          <Month>4</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2010</Year>
          <Month>4</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2010</Year>
          <Month>12</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">20383481</ArticleId>
        <ArticleId IdType="doi">10.1007/s00108-009-2497-5</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>J Clin Endocrinol Metab. 2005 Sep;90(9):5234-40</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15998777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Ophthalmol. 1993 Nov 15;116(5):533-47</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8238212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lancet. 2000 Apr 29;355(9214):1505-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10801172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br J Ophthalmol. 2003 Jun;87(6):773-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12770979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Endocrinol Invest. 2004 Mar;27(3):254-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15165001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Endocrinol Metab. 1995 Sep;80(9):2830-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7673432</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thyroid. 2002 Oct;12(10):855-60</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12487767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Endocrinol. 2001 May;144(5):475-83</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11331213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Intern Med. 1998 Oct 15;129(8):632-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9786811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br J Ophthalmol. 2009 Aug;93(8):1052-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19221109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Exp Clin Endocrinol Diabetes. 2006 Sep;114(8):406-11</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17039420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Endocrinol. 2007 Jan;156(1):33-40</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17218723</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thyroid. 2000 Dec;10(12):1093-100</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11201855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eye (Lond). 2005 Dec;19(12):1286-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15550932</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 1998 Jan 8;338(2):73-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9420337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Clin Invest. 1986 Oct;16(5):415-22</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3100309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Endocrinol (Oxf). 1996 Oct;45(4):477-81</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8959089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Endocrinol (Oxf). 1999 Oct;51(4):503-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10583319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Endocrinol Metab. 2007 Jan;92(1):59-64</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17047020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Curr Opin Endocrinol Diabetes Obes. 2008 Oct;15(5):446-52</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18769218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Z Arztl Fortbild Qualitatssich. 2004 May;98 Suppl 5:45-53</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15255313</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ophthalmology. 2008 Feb;115(2):398-409</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18082885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Endocrinol Invest. 2004 Mar;27(3):265-71</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15165003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Immunol. 2009 Mar;130(3):252-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18964302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Endocrinol Metab. 2006 Sep;91(9):3464-70</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16835285</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Endocrinol Metab. 2004 Jan;89(1):15-20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14715820</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Endocrinol Metab. 2005 Sep;90(9):5321-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15985483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Endocrinol (Oxf). 1995 Jan;42(1):45-50</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7889631</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Endocrinol. 2008 Mar;158(3):273-85</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18299459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Endocrinol Metab. 2001 Aug;86(8):3562-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11502779</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Ophthalmol. 1996 Apr;121(4):426-34</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8604736</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 1992 Jun 25;326(26):1733-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1489388</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Endocrinol (Oxf). 2007 Oct;67(4):607-12</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17880407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Endocrinol. 2006 Sep;155(3):387-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16914591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ophthalmologe. 2007 Sep;104(9):771-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17823804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Endocrinol. 2008 Nov;159(5):609-15</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18628345</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Med Klin (Munich). 2009 May 15;104(5):343-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19444414</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
